New appointment to Devyser’s management team enhances commercial focus
Devyser announces a strengthening of its commercial organization with the appointment of Theis Kipling as Chief Commercial Officer (CCO) with global responsibility for sales, marketing, product management and tech support. Theis Kipling’s employment within Devyser’s management team will commence latest by June 1, 2022. Theis Kipling has a comprehensive commercial background in the global life sciences sector. Theis joins Devyser from his most recent post as CCO at the Swedish biotechnology company Atlas Antibodies, where he was responsible for developing the commercial organization and